Zevra Therapeutics Stock Overlap Studies Hilbert Transform Instantaneous Trendline

ZVRA Stock   9.50  0.07  0.74%   
Zevra Therapeutics overlap studies tool provides the execution environment for running the Hilbert Transform Instantaneous Trendline study and other technical functions against Zevra Therapeutics. Zevra Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Hilbert Transform Instantaneous Trendline study function is designed to identify and follow existing trends. Zevra Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques.

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Zevra Therapeutics price series.

Zevra Therapeutics Technical Analysis Modules

Most technical analysis of Zevra Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zevra from various momentum indicators to cycle indicators. When you analyze Zevra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Zevra Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zevra Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zevra Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Zevra Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zevra Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Zevra Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Zevra Therapeutics, we also check how macroeconomic factors affect Zevra Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number5.268.217.146.78
Receivables Turnover18.751.461.581.5
Hype
Prediction
LowEstimatedHigh
6.149.5012.86
Details
Intrinsic
Valuation
LowRealHigh
4.087.4410.80
Details
Naive
Forecast
LowNextHigh
6.639.9913.35
Details
8 Analysts
Consensus
LowTargetHigh
17.5219.2521.37
Details

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Zevra Therapeutics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zevra Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zevra Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Zevra Therapeutics Pair Trading

Zevra Therapeutics Pair Trading Analysis

When determining whether Zevra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zevra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zevra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zevra Therapeutics Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zevra Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zevra Therapeutics. If investors know Zevra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zevra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.13)
Revenue Per Share
0.575
Quarterly Revenue Growth
0.276
Return On Assets
(0.33)
Return On Equity
(1.31)
The market value of Zevra Therapeutics is measured differently than its book value, which is the value of Zevra that is recorded on the company's balance sheet. Investors also form their own opinion of Zevra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Zevra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zevra Therapeutics' market value can be influenced by many factors that don't directly affect Zevra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zevra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zevra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zevra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.